Inanici Fatma, Yunus Muhammad B
Department of Medicine, University of Illinois College of Medicine at Peoria, One Illini Drive, Peoria, IL 61605, USA.
Curr Pain Headache Rep. 2004 Oct;8(5):369-78. doi: 10.1007/s11916-996-0010-6.
Fibromyalgia syndrome (FMS) is now a recognized clinical entity causing chronic and disabling pain. For several centuries, muscle pains have been known as rheumatism and then as muscular rheumatism. The term fibrositis was coined by Gowers in 1904 and was not changed to fibromyalgia until 1976. Smythe laid the foundation of modern FMS in 1972 by describing widespread pain and tender points. The first sleep electroencephalogram study was performed in 1975. The first controlled clinical study with validation of known symptoms and tender points was published in 1981. This same study also proposed the first data-based criteria. The important concept that FMS and other similar conditions are interconnected was proposed in 1984. The first American College of Rheumatology criteria were published in 1990 and neurohormonal mechanisms with central sensitization were developed in the 1990s. Serotonergic/norepinephric drugs were first shown to be effective in 1986.
纤维肌痛综合征(FMS)如今是一种公认的临床病症,会导致慢性且使人致残的疼痛。几个世纪以来,肌肉疼痛一直被称为风湿病,之后又被称为肌肉风湿病。“纤维织炎”一词由高尔斯在1904年创造,直到1976年才被改为“纤维肌痛”。1972年,斯迈思通过描述广泛疼痛和压痛点奠定了现代纤维肌痛综合征的基础。1975年进行了首次睡眠脑电图研究。1981年发表了第一项对已知症状和压痛点进行验证的对照临床研究。同一项研究还提出了首个基于数据的标准。1984年提出了纤维肌痛综合征与其他类似病症相互关联的重要概念。1990年发表了首个美国风湿病学会标准,20世纪90年代发展出了具有中枢敏化作用的神经激素机制。1986年首次证明血清素能/去甲肾上腺素能药物有效。